Subnavigation

• Influenza
• Surveillance and monitoring
  • Updates
  • FluID
• GISRS and laboratory
  • FluNet
  • National Influenza Centres
  • WHO Collaborating Centres for influenza and Essential Regulatory Laboratories
  • WHO H5 Reference Laboratories
  • Antiviral susceptibility surveillance
  • WHO External Quality Assessment Project
  • Shipping and logistic activities
• PIP Framework
  • Advisory Group
  • Virus Sharing
  • Benefit Sharing
• Vaccines
  • Vaccine viruses
  • Vaccine use
• Patient care
  • Clinical management
  • Antivirals
• Human animal interface
  • Avian influenza in humans
  • Swine influenza in humans
• Public health preparedness
• Information resources
  • Research
  • Training
  • Publications

Avian influenza: guidelines. recommendations, descriptions

Vaccines and antivirals

• Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines
  February 2011
• Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for the development of candidate vaccine viruses for pandemic preparedness
  pdf, 139kb
  September 2010
• Availability of a new recombinant A(H5N1) vaccine virus
  August 2010
• Availability of a new recombinant A(H5N1) vaccine virus
  July 2010
• Availability of a new recombinant A(H5N1) vaccine virus
  June 2010
• Status of development and availability of A(H5N1) candidate vaccine viruses
  June 2010
• Availability of a new recombinant H5N1 vaccine virus
  May 2009
• Availability of new recombinant H5N1 vaccine viruses
  March 2009
• Availability of new recombinant H5N1 vaccine virus
  10 September 2008
• Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile
  May 2008
• Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003–2006 influenza seasons
  27 April 2007, vol. 82, 17 (pp 141–152)
• Early release of influenza viruses for pandemic influenza vaccine development
  01 February 2007
• Availability of new recombinant H5N1 vaccine virus
  21 December 2006
• Global pandemic influenza action plan to increase vaccine supply
  23October 2006
• WHO procedures for obtaining release of H5N1 sequences to the public domain
  23 August 2006
• Availability of new H5N1 prototype strain for influenza pandemic vaccine development
  June 2006
• Availability of new H5N1 prototype strain for influenza pandemic vaccine development
  May 2006
• WHO Rapid Advice Guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus
  May 2006
• Availability of new H5N1 prototype strain for influenza pandemic vaccine development
  March 2006
• 
  28 October 2005
• H5N1 avian influenza – first steps towards development of a human vaccine
  12 August 2005
• 
  20 July 2005
• Access to influenza A(H5N1) viruses
  April 2005
• Availability of H5N1 prototype strains for influenza pandemic vaccine development
  February 2005
• 
  November 2003